Literature DB >> 638021

Fibrinolytic activity of cultured cells derived during ethylnitrosourea-induced carcinogenesis of rat brain.

T A Hince, J P Roscoe.   

Abstract

Using a fibrin-agarose-overlay technique, high levels of plasminogen-dependent fibrinolytic activity have been demonstrated in cell lines derived from an ethylnitrosourea-induced glioma of the rat brain. Cell lines derived from normal adult rat brain showed only low levels of activity. The degree of lysis produced by a cell line was dependent on the average number of cells per colony, and a different pattern of response was observed for tumour and normal cell lines. A good positive correlation existed between the level of fibrinolytic activity, growth in agar and tumourigenicity of a cell line. Fibrinolytic activity was associated with cell lines derived at various times in the latent period, before the appearance of a visible tumour. Many cell lines derived from rat brains at 57-60 (E7), 90-91 (E8) and 111-112 (E6) days after transplacental exposure to ethylnitrosourea showed fibrinolytic activity, and in the latter group the close association with growth in agar and tumourigenicity was also demonstrated. Results from cell lines derived in the E7 and E8 experiments indicated that the possession of fibrinolytic activity preceded the ability of cells to form colonies in agar.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638021      PMCID: PMC2009526          DOI: 10.1038/bjc.1978.63

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.

Authors:  M Wu; G K Arimura; A A Yunis
Journal:  Biochemistry       Date:  1977-05-03       Impact factor: 3.162

2.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

3.  Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses.

Authors:  J P Quigley; L Ossowski; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

4.  Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

Authors:  J Unkeless; K Dano; G M Kellerman; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

5.  Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

Authors:  J K Christman; G Acs
Journal:  Biochim Biophys Acta       Date:  1974-03-27

6.  Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40.

Authors:  R Pollack; R Risser; S Conlon; D Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

7.  Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture.

Authors:  B Astedt; L Holmberg
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

8.  Fibrinolysis associated with human neoplasia: production of plasminogen activator by human tumours.

Authors:  B Nagy; J Ban; B Brdar
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

9.  Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm.

Authors:  S Strickland; E Reich; M I Sherman
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

10.  Production of plasminogen activator by established cell lines of mouse origin.

Authors:  D B Rifkin; R Pollack
Journal:  J Cell Biol       Date:  1977-04       Impact factor: 10.539

View more
  12 in total

1.  Changes in surface morphology associated with ethylnitrosourea-induced malignant transformation of cultured rat brain cells studied by scanning electron microscopy.

Authors:  D P Winslow; J P Roscoe; P M Rowles
Journal:  Br J Exp Pathol       Date:  1978-10

2.  The fine structure of cloned cells from normal adult rat brain.

Authors:  G J Pilkington; P L Lantos; J P Roscoe
Journal:  Experientia       Date:  1980-02-15

3.  Cellular heterogeneity in an ethylnitrosourea-induced glioma: malignancy, karyology and other properties of tumour cell types.

Authors:  P J Claisse; J P Roscoe; P L Lantos
Journal:  Br J Exp Pathol       Date:  1979-04

Review 4.  Invasiveness of primary brain tumors.

Authors:  O D Laerum; R Bjerkvig; S K Steinsvåg; L de Ridder
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

5.  Morphological analysis of malignancy: a comparative study of transplanted brain tumours.

Authors:  P Davaki; P L Lantos
Journal:  Br J Exp Pathol       Date:  1980-12

6.  Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors.

Authors:  J S Rao; A Rayford; R A Morantz; B W Festoff; R Sawaya
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

Review 7.  Hemostatic changes in patients with brain tumors.

Authors:  L Thoron; E Arbit
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Effect of 12-O-tetradecanoylphorbol-13-acetate on two charateristics of transformation acquired sequentially by ENU-exposed rat brain cells.

Authors:  J P Roscoe; T A Hince; P J Claisse; D P Winslow
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640

9.  Different response of ENU-exposed and unexposed rat brain cells to cholera toxin at early passages in culture.

Authors:  P J Claisse; J P Roscoe
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

10.  Interrelationship between differentiation and malignancy-associated properties in glioma.

Authors:  M C Frame; R I Freshney; P F Vaughan; D I Graham; R Shaw
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.